Parasite | Eso | Sto | Cancer | ESD
[SMC Monday GI conference 2016-9-12]
1. FAP (familial adenomatous polyposis) - ÀÓ»ó°»ç Á¶¼¼Èñ
Desmoid tumorµµ Áß¿äÇÑ »çÀÎ Áß ÇϳªÀÏ ¼ö ÀÖÀ½À» ÀØÁö ¸¿½Ã´Ù.
* Âü°í: EndoTODAY FAP
2. Cold snare polypectomy vs cold forceps polypectomy - ÀÓ»ó°»ç ¿ÀÀμö
EndoTODAY À嵿°æ ±³¼ö´Ô staff lecture on polypectomy
2014³â 7¿ù 13ÀÏ °Ç±¹´ë½ÉÆ÷Áö¾ö Yoji Takeuchi ¼±»ý´Ô ¹ßÇ¥ ÀÚ·á Áß
Ç×Ç÷ÀÀ°íÁ¦ »ç¿ëȯÀÚ¿¡¼ cold snare polypectomy(CSP)°¡ ´õ ¾ÈÀüÇÒ ¼ö ÀÖ½À´Ï´Ù (Horiuchi A. GIE 2014). Cold snare polypectomy¿¡¼´Â Àü±â ¼Õ»óÀÌ ¾ø°í cutting depth°¡ ³·±â ¶§¹®¿¡ ÃâÇ÷ÀÌ ÀûÀº °ÍÀ¸·Î »ý°¢µË´Ï´Ù.
* Âü°í: EndoTODAY À嵿°æ ±³¼ö´Ô staff lecture on polypectomy - 3 mm ÀÌÇÏ´Â cold biopsy·Î Á¦°ÅÇÒ ¼ö ÀÖÀ¸³ª À̺¸´Ù Å©¸é cold biopsy·Î Á¦°ÅÇÑ ÈÄ residual tumor°¡ ¸¹ÀÌ ³²½À´Ï´Ù. 4-7 mm ´Â cold snaringÀ¸·Î Á¦°ÅÇÒ ¼ö ÀÖ½À´Ï´Ù. Snare·Î Á¦°ÅÇϸé snare polypectomy·Î ó¹æÇÒ ¼ö ÀÖ½À´Ï´Ù. Cold snaring ÇÒ ¶§¿¡´Â tentingÀ» ÇÏÁö ¾Ê¾Æ¾ß ÇÕ´Ï´Ù. Cold snaring ÈÄ ¾à°£ÀÇ oozingÀº ´ëºÎºÐ ÀúÀý·Î ¸Ü½À´Ï´Ù. Delayed bleedingÀº hot snaringº¸´Ù Àû½À´Ï´Ù.
* Âü°í: EndoTODAY 2014³â ¼Òȱ⳻°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° Áß ¹Úµ¿ÀÏ ±³¼ö´Ô °ÀÇ
1) ÇöÀç ¿ì¸®´Ï¶ó¿¡¼ ´ëÀå¾ÏÀº ¸Å³â 6.2%¾¿ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù (2011³â º¸°Çº¹ÁöºÎ). ¸Å³â 25.3%¿¡¼ Áõ°¡ÇÏ°í ÀÖ´Ù´Â °©»ó¼±¾ÏÀ» Á¦¿ÜÇÏ°í ´ëºÎºÐÀÇ ¾ÏÀº ´õ ÀÌ»ó Áõ°¡ÇÏÁö ¾Ê°í Àְųª °¨¼ÒÇϱ⠽ÃÀÛÇÑ °Í°ú´Â ´ëÁ¶ÀûÀÔ´Ï´Ù.
2) ÃÖ±Ù adenoma detection rate´Â ²ÙÁØÈ÷ »ó½ÂµÇ°í ÀÖ½À´Ï´Ù. 50´ë ÀÌ»ó ³²¼ºÀÇ °æ¿ì 55% ÀÌ»óÀÔ´Ï´Ù.
3) Serrated adenoma¿¡¼ ¹ß»ýÇÏ´Â ¾ÏÀÇ °æ¿ì À۾Ƶµ verticalÇÏ°Ô ÀÚ¶ó´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ¹ß°ßµµ ¾î·Á¿ì¹Ç·Î ÁÖÀÇÇØ¾ß ÇÕ´Ï´Ù.
4) 5¹Ð¸® ÀÌÇÏÀÇ ¼±Á¾À» cold biopsy·Î Á¦°ÅÇÒ ¶§ 39%(21/54)¿¡¼¸¸ Á¦°ÅµÈ´Ù´Â º¸°í°¡ ÀÖ¾ú½À´Ï´Ù (Ethymiou. Endoscopy 2011;43:312). ±×·¯³ª °ºÏ»ï¼ºº´¿ø¿¡¼ µ¿ÀÏÇÑ ÇÁ·ÎÅäÄÝ·Î ½ÃÇàÇÑ ¿¬±¸¿¡ µû¸£¸é 90.7%(78/86)ÀÇ 5¹Ð¸® ÀÌÇÏ ¼±Á¾ÀÌ cold biopsy·Î ¿ÏÀüÈ÷ Á¦°ÅµÇ¾ú½À´Ï´Ù (Jung. Endoscopy 2013:45:1024). ¾ó¸¶³ª ½Å°æ½á¼ Ä¡·áÇϴ°¡¿¡ µû¶ó¼ °á°ú°¡ »ó´çÈ÷ ´Þ¶óÁüÀ» ¾Ë ¼ö ÀÖ½À´Ï´Ù. ¹Úµ¿ÀÏ ±³¼ö´ÔÀº º´¼Ò¿¡ Á÷°¢À¸·Î Á¢±ÙÇϸé ÁÁ´Ù´Â tipÀ» ¾Ë·ÁÁּ̽À´Ï´Ù.
5) Defiant polyp = lesion that defies resection by the standard snare polypectomy
(1) > 2 cm, flat, sessile
(2) Àå°ü µÑ·¹ÀÇ 1/3ÀÌ»ó, haustral fold µÎ °³ ÀÌ»óÀ» ħÀ±
(3) location - IC valve, appendiceal orfice°¡ º´º¯ÀÇ Áß¾Ó¿¡ À§Ä¡
(4) ³»½Ã°æÀ» 5-6½Ã ¹æÇâÀ¸·Î °íÁ¤½ÃÅ°±â ¾î·Á¿î °æ¿ì
(5) °Ô½Ç¿¡ ÀÎÁ¢Çϰųª °Ô½ÇÀÇ ³»ºÎ¿¡ ÀÖ´Â Æú¸³6) Korean guideline for postpolypectomy surveillance (Yang DH. Clin Endosc 2012;45:44-61)
(1) High risk group - surveillance after 3 years
- >= 3 adenomas
- any adenoma larger than 10 mm
- VTA or VA
- HGD
- SSP >= 10 mm
(2) Without any high-risk findings; surveillance after 5 years
© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.